Society guideline links: Medullary thyroid cancer

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Thyroid nodules and cancer" and "Society guideline links: Pheochromocytoma and paraganglioma".)

United States

●American College of Radiology (ACR): ACR Appropriateness Criteria thyroid disease (2018)

●American Thyroid Association (ATA): Revised guidelines for the management of medullary thyroid cancer (2015)

Europe

●European Society for Medical Oncology (ESMO): Clinical practice guideline on the use of systemic therapy in advanced thyroid cancer, update (2022)

•European Society for Medical Oncology (ESMO): Clinical practice guidelines on thyroid cancer (2019)

●European Thyroid Association (ETA): Guidelines for metastatic medullary thyroid cancer (2012)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on thyroid cancer – Assessment and management (2022)

●United Kingdom National Multidisciplinary Guidelines: Management of thyroid cancer (2016)

●British Thyroid Association (BTA): Guidelines for the management of thyroid cancer (2014)

Japan

●Japan Associations of Endocrine Surgeons (JAES): The revised clinical practice guidelines on the management of thyroid tumors – Core questions and recommendations for treatments of thyroid cancer (2020)